CAS No.:127045-41-4
Name: Pazufloxacin
Details Introduction
TOXICITY DATA with REFERENCE:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD | oral | > 2gm/kg (2000mg/kg) | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. | |
dog | LDLo | intravenous | 400mg/kg (400mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD GASTROINTESTINAL: NAUSEA OR VOMITING |
Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
mouse | LD | oral | > 5gm/kg (5000mg/kg) | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. | |
mouse | LD | subcutaneous | > 5gm/kg (5000mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
mouse | LD50 | intravenous | 783mg/kg (783mg/kg) | BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
rat | LD | oral | > 5gm/kg (5000mg/kg) | Chemotherapy Vol. 43(Suppl, | |
rat | LD | subcutaneous | > 5gm/kg (5000mg/kg) | SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" | Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
rat | LD50 | intravenous | 341mg/kg (341mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: CONVULSIONS OR EFFECT ON SEIZURE THRESHOLD LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
Japanese Journal of Antibiotics. Vol. 48, Pg. 754, 1995. |
Consensus Reports:
SAFETY PROFILE:
Hazard Codes: Xn,C,F
Risk Statements: 20/21/22-34-11
R11: Pazufloxacin (CAS NO.127045-41-4) is highly flammable.
R34: Causes burns.
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed.
Safety Statements: 45-36/37/39-26-16
S16: Keep Pazufloxacin (CAS NO.127045-41-4) away from sources of ignition.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
RTECS: UU8815300
Standards and Recommendations:
Analytical Methods:
Related Searches
Related Suppliers
- Dayang Chem (Hangzhou) Co.,Ltd.
- Jinan Finer Chemical Co., Ltd
- hangzhou verychem science and technology co.ltd
- Fraken Biochem Co., Ltd.
- SHANDONG JINCHENG PHARMACEUTICALS AND CHEMICALS CO.,LTD
- PARAGOS
- Zhejiang Myjoy Import & Export Co.,Ltd.
- Wuxi Weikang Curative Chemical Co., Ltd.
- Wuhan Seraphic Technology Co.,Ltd
- Manus Aktteva Biopharma LLP
- Shenyang Zhongchen Chemical Technology Development Co., Ltd
- Hubei Hengluyuang Technology Co.,Ltd
- privatedrugssupply
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione